Drug Approval | June 13, 2025
USFDA inspection at the API manufacturing plant located in Mekaguda, Hyderabad
The company received 1 (One) observation in the Form-483
The company received 1 (One) observation in the Form-483
In light of the contributions of these three institutes, it was decided to organize a CSIR Startup Conclave in Hyderabad. The event, scheduled for April 22–23, 2025
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
Amgen India investment totals $200 million through 2025
Krishna Institute of Medical Sciences Ltd enters into agreement with Splendid Hospitals
The company is committed to revolutionizing API development by advancing synthesis and analytical processes that enhance quality and impact lives
Lilly plans to hire approximately more than 1,000 new highly-skilled team members
The company has received the GMP Certification after successful closure of the inspection
With 6 operation hubs and 18 offices across North America, Europe, and Asia, Indegene’s client base includes the world’s top 20 biopharma companies
The GMP inspection assessed mammalian and microbial drug substance manufacturing facility sections
Subscribe To Our Newsletter & Stay Updated
